Clinical Trials in Maryland

Showing 11301-11320 of 19,983 trials

Behavioral Depression Treatment for African American HIV-infected Substance Users

NCT01351454

The objective of the current study is to test a novel, behavioral approach to treat depressive symptoms and improve HIV medication adherence and subsequent physical health outcomes among African American HIV-infected substance users residing in inner-city Washington, DC. This treatment will serve as a compliment to standard residential and follow-up outpatient substance use treatment, with the goal of reducing depressive symptoms and improving HIV medication adherence, physical health, and substance use outcomes.

DepressionSubstance Use

University of North Carolina, Chapel Hill61 participantsStarted Sep 2008

Washington D.C., District of Columbia, United States • College Park, Maryland, United States

TERMINATEDNA17 miles

PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)

NCT00459693

The purpose of this protocol is to measure a receptor in the brain using positron emission tomography (PET) that is involved in inflammation.

HIV-DementiaHIV-Associated Cognitive Motor ComplexAIDS Encephalopathy+4 more

National Institute of Mental Health (NIMH)40 participantsStarted Apr 2007

Bethesda, Maryland, United States

Behavioral Depression Treatment for African American HIV-infected Substance Users

PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)

Find Trials by Condition in Maryland

Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer

Identification of Herpes Simplex Virus (HSV) Shedding in the Female Genital Tract of Pregnant and Nonpregnant Women by GeneXpert PCR, Routine PCR, and Culture

Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year

A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis

ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer

Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation

Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke

Clinical Evaluation of Flortaucipir F 18

Renal AL Amyloid Involvement and NEOD001

A Study of Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant Ovarian

Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder

Debio 1347-101 Phase I Trial in Advanced Solid Tumours With Fibroblast Growth Factor Receptor (FGFR) Alterations

Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis

Safety and Efficacy Study of Single Weekly Bortezomib in Newly Diagnosed Multiple Myeloma

A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19

18F-AV-1451 Autopsy Study

A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects

Use of Recombinant Adenovirus Therapy to Treat Localized Prostate Cancer